Half-year report · Q2
4894.TEDINET S100US0G
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 29
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8m | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥23m | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | −¥399m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥464m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥628m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥464m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥466m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥632m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥467m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥5.8bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥6.2bn | at 2024-03-31 | Cons. | Assets |
| Total liabilities | ¥176m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥201m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥5.6bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.0bn | at 2024-03-31 | Cons. | Net assets |
| Cash and deposits | ¥4.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥715m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥451m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥89m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥35m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥66m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-58.43 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-85.86 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 96.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 306
| Item | Context | Value | Unit |
|---|---|---|---|
| Description of fact that companys business comprises single segment | CurrentYTDDuration | Original text (Japanese)当社グループは、再生医療等製品事業の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |